C. Reithmann et al., A POSTRECEPTOR DEFECT OF ADENYLYL-CYCLASE IN SEVERELY FAILING MYOCARDIUM FROM CHILDREN WITH CONGENITAL HEART-DISEASE, European journal of pharmacology, 330(1), 1997, pp. 79-86
The aim of this study was to determine whether a defect at the post-re
ceptor level of adenylyl cyclase may also contribute to the decreased
effectiveness of cAMP-increasing agents in severely failing patients w
ith congenital heart disease. The severity of congestive heart failure
in 31 patients with congenital heart disease was graded by a scoring
system which included a description of historical and clinical variabl
es. Patients were divided into a group with no or mild heart failure (
score less than or equal to 6) and a group with severe heart failure (
score > 6), beta-Adrenoceptor-stimulated adenylyl cyclase activity was
significantly decreased by 65% in patients with severe heart failure
in comparison to the group of patients with no or mild heart failure.
In addition, receptor-independent adenylyl cyclase stimulation by fors
kolin was reduced by 52% in patients with score > 6 compared to patien
ts with score less than or equal to 6. This post-receptor defect of ad
enylyl cyclase was apparently due to a decrease in the activity of cat
alytic subunit of adenylyl cyclase as adenylyl cyclase stimulation by
forskolin in the presence of Mn2+ which uncouples catalytic subunit fr
om the G proteins, G(s) and G(i), was also significantly diminished in
the patients with severe heart failure. In contrast, the level of inh
ibitory G protein alpha-subunits was apparently not different in the t
wo groups. In summary, the data indicate that a defect at the catalyti
c subunit of adenylyl cyclase apparently contributes to the decreased
effectiveness of cAMP-increasing agents in severely failing patients w
ith congenital heart disease. (C) 1997 Elsevier Science B.V.